Press Release

Global Antiviral Drugs Market to Witness a Growth During 2024-2032, Aided by the Growing Incidences of Viral Infections Globally

Global Antiviral Drugs Market

According to a new report by EMR titled, ‘Global Antiviral Drugs Market Report and Forecast 2024-2032’, the market attained a value of above USD 55.17 billion in 2023. The market is anticipated to grow at a CAGR of 4.1% during the forecast period of 2024-2032 to attain a value of USD 79.21 billion by 2032.

The global market for antiviral drugs is being driven by the growing prevalence of viral infections across the globe such as hepatitis virus, among others. This is driving the demand for effective drugs and treatments to eradicate harmful viruses from the body and contain the spread of the disease. In addition, the rising awareness among consumers regarding the availability of antiviral drug treatments also contributes to the market expansion. Further, the rising geriatric population with a heightened susceptibility to infectious diseases and ailments is also expected to bolster the demand for antiviral drugs in the forecast period. The increased investments by the leading market players in the research and development of advanced antiviral treatments such as vaccines are also expected to prove beneficial for the market growth during 2024-2032.


In 2020, with the emergence of the novel coronavirus, the market players increasingly invested in the development of advanced antiviral drugs to treat and combat COVID-19 infection. For instance, in October 2020, Gilead Sciences, Inc. (NASDAQ: GILD) announced that its Antiviral Veklury® (remdesivir) has received US Food and Drug Administration approval for the treatment of COVID-19. It became the first and only COVID-19 treatment in the United States that can help prevent the replication of SARS-CoV-2, a virus that causes COVID-19. Furthermore, in March 2022, AbbVie (NYSE: ABBV) and Scripps Research announced a collaboration aimed at the development of direct-acting antiviral treatments for COVID-19. The emergence of newer COVID-19 variants and the rising demand for advanced treatment solutions are supporting these research activities.


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


Market Breakup by Drug Class, Type, Application, and Region:

  • The market is divided, based on drug class, into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and neuraminidase inhibitors, among others.
  • On the basis of type, the market can be distributed into branded and generics.
  • Based on application, the industry is segregated into HIV, Hepatitis, Influenza, and Herpes, among others.
  • Region-wise, the global market for antiviral drugs can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.


Key Findings of the Report:

  • The global market for antiviral drugs is being driven by the rising prevalence of viral infections worldwide.
  • The potential risk of the emergence of the newer COVID-19 variant is driving the market growth. 
  • The rising geriatric population, with a heightened susceptibility to severe diseases and infections is also adding to the market expansion. 
  • The rising investments by the leading market players in the development of advanced antiviral treatment solutions are further propelling the market growth.


Key Offerings of the Report:

  • The EMR report gives an overview of the global market for antiviral drugs for the periods (2018-2023) and (2024-2032).
  • The report also offers historical (2018-2023) and forecast (2024-2032) market information for the drug classes, types, applications, and regions of antiviral drugs.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.


The major players in the global antiviral drugs market are Gilead Sciences, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., AbbVie Inc., Merck and Co., Inc., Johnson and Johnson Services, Inc., Cipla Inc., Bristol-Myers Squibb Company, Aurobindo Pharma Limited, and Dr. Reddy’s Laboratories Ltd., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.


About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.


EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.


Contact Us:

Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790


*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.